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managed as DHF. Mortality rate amongst dengue IgM posi-
tives was 6.02% (5/83).
Conclusion: The unusual clinical proﬁle necessitates
continuous sero surveillance and monitoring for changing
clinical presentationof dengue infection.
doi:10.1016/j.ijid.2010.02.1873
40.002
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Background: In September 2008, an outbreak of pneumo-
nia associated with a rare human adenovirus (serotype-14
[HAdV-14]) occurred on a rural island in Southeast Alaska.
To determine risk factors for disease and household trans-
mission characteristics, we investigated pneumonia cases in
three affected island communities.
Methods: Case-patients were island residents who pre-
sented to one of two medical clinics with clinical or
radiological evidence of pneumonia between September 1
and October 27, 2008. Controls from the community were
matched 1:1 to case-patients based on age, sex, and com-
munity of residence. Case-patients, controls, and household
contacts were interviewed for information on demograph-
ics, recent illnesses, medical history, ill contacts, and other
possible exposures. Serum and respiratory specimens were
also collected. Risk factors for pneumonia were determined
using exact multivariate conditional logistic regression.
Household HAdV-14 attack rates were calculated.
Results: Thirty-two pneumonia case-patients and 32
matched controls were interviewed. Among case-patients,
the median age was 47.5 (range, 2-95 years), 75% were
male, and 74% were Alaska Native. Nine cases resulted
in hospitalization and there was one death. Twenty-one
(66%) case-patients and no controls were infected with
HAdV-14 (p < 0.001). Independent risk factors for pneu-
monia were contact with a known HAdV-14 pneumonia
case-patient (OR = 18.3, 95%CI = 2.0-&), current smoking
(OR = 6.7, 95%CI = 0.9-&), and having neither traveled off-
island nor attended at a large public gathering (OR = 14.7,
95%CI = 2.0-&). Fourteen (67%) of the 21 HAdV-14-infected
case-patients belonged to a single network of people who
socialized and often smoked together and infrequently trav-
eled off-island. HAdV-14 infection occurred in 43% of case-
versus 5% of control-household contacts (p = 0.005).
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Conclusion: This is one of the ﬁrst recognized civil-
an community outbreaks of HAdV-14 since the virus ﬁrst
ppeared in California in 2003. Demographic characteristics
nd illness patterns in case-patients were similar to those
bserved in other HAdV-14 outbreaks in Oregon and Wash-
ngton State in 2007, with disease mostly occurring in adult
ale smokers. In this setting, HAdV-14 appeared to have
pread mostly among close contacts in the home or within
certain social network whose members often reported
moking or sharing smoking materials with other HAdV-14
ase-patients. Lack of HAdV-14 infection in controls and
heir household contacts suggests wide-spread transmission
id not occur, either previously or during this pneumonia
utbreak.
oi:10.1016/j.ijid.2010.02.1874
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Background: In 2006 and 2008, two new vaccines were
ecommended for routine vaccination of US infants against
otavirus. We assessed vaccine uptake and its impact on
otavirus disease in US children.
Methods: To measure vaccine uptake, we examined data
rom sentinel immunization information system (IIS) sites
n eight different US locations. Coverage with at least 1
ose of rotavirus vaccine was measured at age 5 months,
nd compared with coverage of other established child-
ood vaccines, DTaP and pneumococcal vaccine, given at the
ame age. To measure vaccine impact, we examined data
rom 2000-2009 on laboratory detections of rotavirus from
national network of ∼70 laboratories to assess trends and
iming of rotavirus activity. Data from a subset of 29 labo-
atories that consistently reported for ≥30 weeks for each
eason during 2000-2009 were used to measure national and
egional changes in rotavirus test results.
Results: By March 2009, coverage with 1 dose of rotavirus
t age 5 months has reached about 60%-70% across most
f the IIS sites, a level that is about 10%-20% lower than
hat of DTaP and pneumococcal vaccine. Concurrent with
ncreasing rotavirus vaccine coverage, rotavirus activity dur-
ng the 2007-2008 and 2008-2009 rotavirus seasons declined
y 64% and 60%, respectively, compared with pre-vaccine
ears during 2000-2006. In addition, compared with prevac-
ine years, the onset of both the 2007-2008 and 2008-2009
otavirus seasons was delayed by 11 weeks and 6 weeks,
espectively, and the seasons were shorter, lasting 14 and 17
eeks, respectively, compared with 26 weeks in 2000-2006.
egional differences in rotavirus activity were observed,
ith the West census region having a lower reduction and
ess delayed onset than all other regions in 2007-2008 and a
reater reduction andmore delayed onset than other regions
n 2008-2009.
Conclusion: Uptake of rotavirus vaccine in US chil-
ren has increased since vaccine implementation. However,
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otavirus vaccine coverage remains slightly lower than that
f other established childhood vaccines and factors that
ight account for this difference should be examined. Fol-
owing rotavirus vaccine introduction, rotavirus activity in
S children has declined and disease seasonality has been
ltered compared with prevaccine years. Factors that might
xplain the regional differences in changes in rotavirus
ctivity after vaccination should be explored.
oi:10.1016/j.ijid.2010.02.1875
0.004
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Background: Diarrhea is the second leading cause of
eath in Guatemalan children <5 years of age. To evalu-
te the potential health beneﬁts of new vaccines against
otavirus, we assessed the burden of rotavirus diarrhea in
uatemalan children.
Methods: We examined data from an active population-
ased surveillance system in Santa Rosa, Guatemala from
ctober 2007 through September 2009 among children <5
ears of age presenting to the hospital or ambulatory clinics.
pecimens were collected from patients with acute diar-
hea (≥3 loose stools in 24 hours during last seven days)
nd tested for rotavirus via enzyme immunoassay. Geno-
yping via reverse-transcriptase polymerase chain reaction
as performed on rotavirus positive specimens. Results were
tratiﬁed by age group and setting.
Results: 906 patients identiﬁed with diarrhea during the
tudy period provided a fecal specimen for rotavirus testing.
f the specimens tested, 291(35%) were hospitalized and
15 (74%) were ambulatory patients. Rotavirus accounted
or 90 (33%) hospitalizations and 57 (9%) ambulatory vis-
ts for diarrhea annually. Rotavirus conﬁrmed episodes had
marked seasonality as 80% (N = 72) of cases occurred
n January and February. During these months, rotavirus
ccounted for 59% of hospitalizations and 31% of ambula-
ory visits for diarrhea. More than 85% (N = 123) of children
ith rotavirus were <24 months. During the 2008 rotavirus
eason, the predominant rotavirus genotype identiﬁed in 15
f 27 (56%) samples tested was G1P8. Less common strains
ncluding 5 (19%) of the G12 genotype were also observed.
Conclusion: This analysis highlights the prominent role of
otavirus as a cause of severe diarrhea in children <5 years of
ge in Santa Rosa, Guatemala. Currently available vaccines
gainst rotavirus have demonstrated high effectiveness in
reventing severe disease caused by the predominant cir-
ulating strain (G1P8) identiﬁed in Guatemala during the
f
e
eternational Congress on Infectious Diseases (ICID) Abstracts
008 season. Although many factors must be considered by a
ountry prior to the decision to introduce vaccine nationally,
hese data underscore the substantial burden of rotavirus
isease on the Guatemalan healthcare system.This active
opulation-based surveillance system will provide a solid
latform for the assessment of rotavirus vaccine impact
fter introduction.
oi:10.1016/j.ijid.2010.02.1876
0.005
urveillance for epidemic of enterovirus infections in Tai-
an in 2008
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Background: The emergence of enterovirus 71 (EV71) in
aiwan in October, 2007 resulted in a large epidemic of
and-foot-and-mouth disease (HFMD) or herpangina in young
hildren in 2008. EV71 patients may suffer from serious neu-
ological complications or even deaths. The aims of this
tudy were to describe the framework of the surveillance
ystems for enterovirus infections and to characterize this
pidemic in Taiwan in 2008.
Methods: At Taiwan Centers for Disease Control (Tai-
an CDC), there were four systems established for the
urveillance of enterovirus infections. First, we used the
entinel surveillance with more than 650 clinics for report-
ng the number of HFMD or herpangina in outpatient weekly.
econd, the National Notiﬁable Disease Surveillance Sys-
em (NNDSS) was used for reporting the hospitalized cases
ith severe complications. Third, the laboratory surveil-
ance consisted of 13 contract laboratories and 286 clinics
or testing and collecting samples, respectively. Fourth, Tai-
an CDC cooperated with the University of Pittsburgh to
evelop a syndromic surveillance, which is called the Real-
ime and Outbreak Surveillance (RODS) system, covering 80%
f the emergency visits nationally. The Taiwanese RODS sys-
em used the ICD-9-CM code of 074.0 and 074.3 to monitor
nterovirus infections. A web-based decision support sys-
em for this epidemic was also developed for displaying the
tatistics and epidemic curves of the four systems in real
ime.
Results: The epidemic started in week 11, peaked in
eek 25, and was subsiding gradually. The sentinel physi-
ians reported 72,610 visits in one epidemic wave, which
epresents 18% of the ones nationally. 373 cases of severe
omplications (including 14 deaths) were reported through
he NNDSS. Among those, 347 cases (93%) were EV71. A
eb-based system with automated updates daily for the
ublic to browse the statistics and epidemic curves of the
eported cases in the NNDSS was also released then. There
ere 11,150 specimens tested and 3,724 (33%) enterovirus
solated in the laboratory surveillance. The three most iso-
ated types were Coxsackie A2 (CA2), EV71 (B5 was the
ajor subtype), and Coxsackie B4 (CB4). The real-time datarom the RODS helped us better track the trend of the
pidemic.
During the large epidemic of enterovirus infections, our
stablished surveillance systems are helpful for informing
